Doctolib
Funding History
| Series D · 03/2019 | $1.1B |
|---|---|
| Series F · 03/2022 | $6.4B |
| Secondary share sale · 04/2026 | $3.9B |
About
Founded in 2013 by Stanislas Niox-Chateau, Jessy Bernal, and Ivan Schneider, Doctolib began as an online scheduling tool for independent physicians in France before expanding to serve hospitals, clinics, and allied health professionals.
- patientAccounts
- 80 million patient accounts across France, Germany, Italy, and the Netherlands
- healthcareProfessionalSubscribers
- 400,000 healthcare-professional subscribers
- annualRecurringRevenue
- €348 million ARR reported for 2024
Overview
Doctolib is a French health-technology company, founded in 2013 and headquartered in Paris, that operates an online booking platform connecting patients with doctors, specialists, and other healthcare professionals across France, Germany, Italy, and the Netherlands.
The company has expanded beyond appointment scheduling into a broader software suite for healthcare providers, stated it reached companywide profitability in late 2025, and saw a 2026 private share transaction imply a valuation of roughly 3.6 billion euros, down sharply from its 2022 peak.
Private securities are speculative, illiquid, and involve risk of complete loss of principal. You should be prepared to hold private securities for an extended period; there is no assurance of a secondary market, an IPO, or other liquidity event. You are fully responsible for conducting your own due diligence. Pricing is indicative — nothing here is an offer of securities.